CENTRAL TRUST Co lifted its stake in shares of Danaher Co. (NYSE:DHR) by 1.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,491 shares of the conglomerate’s stock after buying an additional 204 shares during the period. CENTRAL TRUST Co’s holdings in Danaher were worth $2,093,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the company. Next Capital Management LLC acquired a new position in Danaher during the second quarter valued at $31,000. Litman Gregory Asset Management LLC acquired a new position in Danaher during the second quarter valued at $33,000. Altshuler Shaham Ltd lifted its position in Danaher by 59.3% during the second quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 89 shares during the period. Pinnacle Bank lifted its position in Danaher by 52.3% during the third quarter. Pinnacle Bank now owns 262 shares of the conglomerate’s stock valued at $38,000 after purchasing an additional 90 shares during the period. Finally, MRA Associates USA LLC acquired a new position in Danaher during the second quarter valued at $40,000. Institutional investors and hedge funds own 78.47% of the company’s stock.
A number of research analysts recently issued reports on the stock. Argus boosted their target price on shares of Danaher to $165.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. Credit Suisse Group restated an “outperform” rating and set a $151.00 target price on shares of Danaher in a research report on Monday, October 14th. ValuEngine downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Wolfe Research set a $154.00 target price on shares of Danaher and gave the company a “buy” rating in a research report on Friday. Finally, Needham & Company LLC decreased their target price on shares of Danaher from $155.00 to $152.00 and set a “buy” rating for the company in a research report on Monday. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Danaher has a consensus rating of “Buy” and a consensus price target of $145.86.
DHR opened at $136.21 on Tuesday. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $147.33. The company has a debt-to-equity ratio of 0.52, a quick ratio of 3.09 and a current ratio of 3.43. The company has a fifty day moving average of $140.27 and a two-hundred day moving average of $137.91. The stock has a market capitalization of $97.59 billion, a price-to-earnings ratio of 30.13, a PEG ratio of 2.28 and a beta of 0.94.
Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, October 24th. The conglomerate reported $1.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.15 by $0.01. Danaher had a net margin of 12.13% and a return on equity of 11.42%. The company had revenue of $5.04 billion during the quarter, compared to analysts’ expectations of $5.02 billion. During the same quarter in the previous year, the company earned $1.10 earnings per share. The firm’s revenue for the quarter was up 3.8% on a year-over-year basis. On average, equities research analysts forecast that Danaher Co. will post 4.76 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a $0.17 dividend. The ex-dividend date was Thursday, September 26th. This represents a $0.68 dividend on an annualized basis and a yield of 0.50%. Danaher’s payout ratio is 15.04%.
In other news, Chairman Mitchell P. Rales acquired 2,500 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was bought at an average price of $139.52 per share, with a total value of $348,800.00. Following the completion of the acquisition, the chairman now owns 3,030,453 shares of the company’s stock, valued at $422,808,802.56. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.40% of the stock is currently owned by insiders.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: How to invest in blue-chip stocks
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.